PRE-TREATMENT TMPT PHARMACOGENETIC TESTING AND RISK OF NEUTROPAENIA IN PATIENTS TREATED WITH AZATHIOPRINE: RESULTS FROM THE TPMT AZATHIOPRINE RESPONSE TO GENOTYPING AND ENZYME TESTING (TARGET) TRIAL
2009
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI